DayTwo, the world’s largest microbiome discovery platform, has developed a precision nutrition solution that offers a sustainable path to remission for metabolic disease using gut profiling, artificial intelligence, and virtual care. Metabolic disease which includes diabetes, prediabetes, clinical obesity, and NAFLD, affects over 50% of US adults. DayTwo was born out of scientific discovery from the Weizmann Institute including the largest clinical nutrition studies in history.
Негізгі бет DayTwo
Пікірлер